Francesco Donno
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Francesco Donno has a total of 11 co-authors. Here are the top co-authors by number of shared publications:
- Maria Rosaria Ambrosio
Section of Endocrinology, Geriatrics and Internal Medicine, Department of Medical Sciences, University of Ferrara, Ferrara, Italy
3 shared publications Maria Chiara Zatelli
Sezione di Endocrinologia, Geriatria e Medicina Interna, Dipartimento di Scienze Mediche, Università degli Studi di Ferrara, Ferrara, Italia
2 shared publications- Alberto Gobbo
Section of Endocrinology, Geriatrics and Internal Medicine, Department of Medical Sciences, University of Ferrara, 44124 Ferrara, Italy
1 shared publication - Alessandra Ferlini
Medical Genetics Unit, Department of Medical Sciences, University of Ferrara, 44121 Ferrara, Italy
1 shared publication - Federica Bianco
Section of Endocrinology, Geriatrics and Internal Medicine, Department of Medical Sciences, University of Ferrara, 44124 Ferrara, Italy
1 shared publication - Giuseppina Stoico
Medical Genetics Unit, Department of Medical Science and Department of Mother and Child, Ferrara University and Ferrara University Hospital, 44124 Ferrara, Italy
1 shared publication
Latest Publications
- Open Access
- 13 June 2026
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 15 (12) , 4609
Chung–Jansen Syndrome in a Young Woman with a PHIP Variant: Severe Obesity, Intellectual Disability, and Endocrine Abnormalities
Background: Chung–Jansen syndrome (CHUJANS) is a rare autosomal dominant genetic condition caused by pathogenic variants in the PHIP gene, which encodes a protein involved in neurodevelopmental processes and IGF-1 signalling. The phenotype is characterised by variable degrees of intellectual disability, early-onset obesity or overweight, distinctive facial dysmorphisms, and behavioural disturbances. We here present a case of Chung–Jansen syndrome with a detailed endocrine work-up, highlighting the metabolic component of this syndrome. Case Presentation: We describe the case of a 21-year-old woman referred to our centre for evaluation of oligomenorrhea in the context of severe obesity (BMI 50.4 kg/m2), short stature (151 cm, T [p.(Arg110Cys)] variant in the PHIP gene, already reported in literature and classified as likely pathogenic (ACMG class 4). Segregation analysis in the mother (father was not available for the test) did not reveal the variant, suggesting a de novo origin in the patient. Concurrently, the same analysis revealed a variant of uncertain significance in the ANKRD17 gene, while array-CGH detected a maternally inherited microdeletion of uncertain significance on chromosome X (Xp11.23). Conclusions: This case confirms the association between the PHIP p.(Arg110Cys) variant and the phenotype of Chung–Jansen syndrome, providing a detailed characterisation of the endocrine and psychiatric comorbidities. Indeed, our report expands the knowledge on the endocrine phenotype providing further suggestion for personalised patient management. It underscores the importance of NGS in the diagnostic workup of syndromic obesity with intellectual disability, especially in the presence of negative family history and prior inconclusive genetic testing. This case suggests the inclusion of comprehensive endocrine evaluations in future studies on patients with Chung–Jansen syndrome, in order to support endocrine work-up and facilitate early identification and appropriate management of potentially treatable alterations.
- 13 June 2026
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 15 (12) , 4609
Open AccessChung–Jansen Syndrome in a Young Woman with a PHIP Variant: Severe Obesity, Intellectual Disability, and Endocrine Abnormalities
Background: Chung–Jansen syndrome (CHUJANS) is a rare autosomal dominant genetic condition caused by pathogenic variants in the PHIP gene, which encodes a protein involved in neurodevelopmental processes and IGF-1 signalling. The phenotype is characterised by variable degrees of intellectual disability, early-onset obesity or overweight, distinctive facial dysmorphisms, and behavioural disturbances. We here present a case of Chung–Jansen syndrome with a detailed endocrine work-up, highlighting the metabolic component of this syndrome. Case Presentation: We describe the case of a 21-year-old woman referred to our centre for evaluation of oligomenorrhea in the context of severe obesity (BMI 50.4 kg/m2), short stature (151 cm, T [p.(Arg110Cys)] variant in the PHIP gene, already reported in literature and classified as likely pathogenic (ACMG class 4). Segregation analysis in the mother (father was not available for the test) did not reveal the variant, suggesting a de novo origin in the patient. Concurrently, the same analysis revealed a variant of uncertain significance in the ANKRD17 gene, while array-CGH detected a maternally inherited microdeletion of uncertain significance on chromosome X (Xp11.23). Conclusions: This case confirms the association between the PHIP p.(Arg110Cys) variant and the phenotype of Chung–Jansen syndrome, providing a detailed characterisation of the endocrine and psychiatric comorbidities. Indeed, our report expands the knowledge on the endocrine phenotype providing further suggestion for personalised patient management. It underscores the importance of NGS in the diagnostic workup of syndromic obesity with intellectual disability, especially in the presence of negative family history and prior inconclusive genetic testing. This case suggests the inclusion of comprehensive endocrine evaluations in future studies on patients with Chung–Jansen syndrome, in order to support endocrine work-up and facilitate early identification and appropriate management of potentially treatable alterations.
- 3 November 2025
- Published by Springer Nature in L'Endocrinologo
- Vol. 26 (6) , 787-788
Semaglutide 7,2 mg settimanale in adulti con obesità (STEP UP): un trial randomizzato controllato di fase 3b
- 3 November 2025
- Published by Springer Nature in L'Endocrinologo
- Vol. 26 (6) , 787-788
Semaglutide 7,2 mg settimanale in adulti con obesità (STEP UP): un trial randomizzato controllato di fase 3b
- 14 July 2025
- Published by Springer Nature in L'Endocrinologo
- Vol. 26 (4) , 512-513
Carcinoma papillare della tiroide in età pediatrica: gli esiti dopo chirurgia in assenza di terapia adiuvante con iodio radioattivo
- 14 July 2025
- Published by Springer Nature in L'Endocrinologo
- Vol. 26 (4) , 512-513
Carcinoma papillare della tiroide in età pediatrica: gli esiti dopo chirurgia in assenza di terapia adiuvante con iodio radioattivo